Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$384M |
| 2 |
Mondelez International
MDLZ
|
+$125M |
| 3 |
NVIDIA
NVDA
|
+$116M |
| 4 |
Johnson & Johnson
JNJ
|
+$105M |
| 5 |
Church & Dwight Co
CHD
|
+$55.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$276M |
| 2 |
Apple
AAPL
|
+$180M |
| 3 |
Duke Energy
DUK
|
+$75.7M |
| 4 |
ConocoPhillips
COP
|
+$73.6M |
| 5 |
Broadcom
AVGO
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.11% |
| 2 | Technology | 9.83% |
| 3 | Utilities | 6.25% |
| 4 | Real Estate | 4.8% |
| 5 | Consumer Discretionary | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SILV
1126
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $616K | ﹤0.01% |
66,637
-243,790
| -79% | -$2.16M |
|
|
TRTX
1127
TPG RE Finance Trust
TRTX
$600M
| $612K | ﹤0.01% |
71,752
-62,273
| -46% | -$547K |
|
|
IAS
1128
DELISTED
Integral Ad Science
IAS
| $611K | ﹤0.01% |
+56,562
| New | +$608K |
|
1129
Metagenomi Therapeutics
MGX
$45.7M
| $608K | ﹤0.01% |
280,287
+87,524
| +45% | +$304K |
|
|
CTO
1130
CTO Realty Growth
CTO
$825M
| $596K | ﹤0.01% |
+31,320
| New | +$596K |
|
1131
CALL
Boeing
BA
$166B
| $593K | ﹤0.01% |
3,900
-15,700
| -80% | -$2.69M |
|
1132
Ambarella
AMBA
$3.07B
| $591K | ﹤0.01% |
10,482
-79,925
| -88% | -$4.25M |
|
|
CVGW
1133
DELISTED
Calavo Growers
CVGW
| $589K | ﹤0.01% |
+20,631
| New | +$504K |
|
1134
Vanda Pharmaceuticals
VNDA
$322M
| $589K | ﹤0.01% |
+125,650
| New | +$674K |
|
1135
Wolverine World Wide
WWW
$1.71B
| $588K | ﹤0.01% |
+33,767
| New | +$467K |
|
|
UHT
1136
Universal Health Realty Income Trust
UHT
$582M
| $582K | ﹤0.01% |
12,721
-2,896
| -19% | -$125K |
|
1137
Virtus Investment Partners
VRTS
$1.13B
| $581K | ﹤0.01% |
2,776
-984
| -26% | -$211K |
|
1138
EPAM Systems
EPAM
$5.74B
| $579K | ﹤0.01% |
+2,911
| New | +$583K |
|
|
LUCK
1139
Lucky Strike Entertainment
LUCK
$915M
| $579K | ﹤0.01% |
+49,355
| New | +$599K |
|
1140
CALL
Texas Instruments
TXN
$236B
| $578K | ﹤0.01% |
2,800
-16,200
| -85% | -$3.26M |
|
1141
Chemours
CC
$2.32B
| $574K | ﹤0.01% |
+28,237
| New | +$577K |
|
1142
PUT
AbbVie
ABBV
$467B
| $572K | ﹤0.01% |
2,900
-20,800
| -88% | -$3.88M |
|
1143
Tactile Systems Technology
TCMD
$529M
| $570K | ﹤0.01% |
+39,047
| New | +$505K |
|
1144
Alamo Group
ALG
$2.01B
| $569K | ﹤0.01% |
3,158
-928
| -23% | -$165K |
|
|
BDN
1145
Brandywine Realty Trust
BDN
$548M
| $566K | ﹤0.01% |
+104,127
| New | +$518K |
|
1146
United Microelectronic
UMC
$47.8B
| $566K | ﹤0.01% |
+67,210
| New | +$562K |
|
1147
Warner Music
WMG
$14.5B
| $565K | ﹤0.01% |
+18,036
| New | +$534K |
|
1148
PUT
Morgan Stanley
MS
$336B
| $563K | ﹤0.01% |
5,400
-33,900
| -86% | -$3.41M |
|
1149
VTEX
VTEX
$605M
| $562K | ﹤0.01% |
75,488
+49,904
| +195% | +$347K |
|
1150
Williams Companies
WMB
$86.8B
| $562K | ﹤0.01% |
12,304
-1,198,263
| -99% | -$52.7M |
|
Similar funds
Michael Gelband's Q3 2024 Portfolio in Review
As of Q3 2024, Michael Gelband held 2,213 positions worth $16.4B, up 12% from $14.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Michael Gelband deployed $963M of net new capital in Q3 2024, opening 752 new positions and adding to 404 existing holdings. Its largest new stake was Mondelez International: 1,784,906 shares worth $131M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 10% a quarter earlier, followed by Technology and Utilities.
On the sell side, the largest reduction was ConocoPhillips, an estimated $73.6M trimmed.
- Michael Gelband's largest Q3 2024 buy was Mondelez International: 1,784,906 shares worth $131M.
- Michael Gelband added most to Microsoft in Q3 2024, an estimated $384M increase.
- Michael Gelband's biggest Q3 2024 reduction was ConocoPhillips, cutting an estimated $73.6M.
- Michael Gelband fully exited Amazon in Q3 2024, selling an estimated $276M.
- Michael Gelband's ten largest holdings make up 37% of its $16.4B portfolio in Q3 2024.
- Michael Gelband opened 752 new positions and closed 645 in Q3 2024.
- Michael Gelband's portfolio value rose 12% quarter-over-quarter to $16.4B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.